 Amneal Pharmaceuticals, Inc. NYSE: AMRX Amneal or the Company today announced it has appointed Tasos Konidaris as Senior Vice President, Chief Financial Officer, effective March 12, 2020. Mr. Konidaris succeeds Todd Branning, who is no longer serving in this role, but remains 